247 related articles for article (PubMed ID: 31090311)
1. [Systematic review of efficacy and safety of Lianhua Qingwen Capsules in treatment of viral influenza].
Wang SH; Liu JF; Zhang YL; Dong Z
Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(7):1503-1508. PubMed ID: 31090311
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of Lianhua Qingwen capsule for influenza： a systematic review].
Niu QQ; Chen Y; Liu Y; Mao SZ; Wang H; Zheng WK; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2017 Apr; 42(8):1474-1481. PubMed ID: 29071849
[TBL] [Abstract][Full Text] [Related]
3. [Overview of Meta-analysis of Lianhua Qingwen preparations in treatment of viral diseases].
Li WF; Hu CC; Ding YL; Yuan B
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(16):4505-4516. PubMed ID: 36046880
[TBL] [Abstract][Full Text] [Related]
4. [Systematic review and Meta-analysis of Lianhua Qingwen preparations combined with Oseltamivir in treatment of influenza].
Yan YM; Yang XJ; Zhao CX; Li ZY; Zhao GZ; Guo YH; Li B; Liu QQ
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(15):4238-4247. PubMed ID: 36046914
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019.
Wang DC; Yu M; Xie WX; Huang LY; Wei J; Lei YH
J Integr Med; 2022 Jan; 20(1):26-33. PubMed ID: 34782291
[TBL] [Abstract][Full Text] [Related]
6. Traditional Chinese medicine Lianhua Qingwen treating corona virus disease 2019(COVID-19): Meta-analysis of randomized controlled trials.
Zeng M; Li L; Wu Z
PLoS One; 2020; 15(9):e0238828. PubMed ID: 32915877
[TBL] [Abstract][Full Text] [Related]
7. [Meta-analysis and systematic review of efficacy and safety of Lianhua Qingwen in adjuvant treatment of adult pneumonia].
Lu ZJ; Wu LY; Mou YY; Duan HM; Chen RC; Xiao Y; Zheng WJ
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):1000-1009. PubMed ID: 33645106
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of Lianhua Qingwen combined with conventional antiviral Western Medicine in the treatment of coronavirus disease (covid-19) in 2019: Protocol for a systematic review and meta-analysis.
Zhang X; Cao D; Liu J; Zhang Q; Liu M
Medicine (Baltimore); 2020 Jul; 99(30):e21404. PubMed ID: 32791754
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of Lianhua Qingwen granule in the treatment of non-influenza viral pneumonia: a randomized, double-blind, placebo-controlled, multicenter clinical study.
Ma C; Chen B; Li Y; Gu L; Dong J; Xu Z; Wei L; He Z; Nie X; Feng S; Cao B; Sun L; Yang L; Li X; Jiang R
Front Med (Lausanne); 2023; 10():1302219. PubMed ID: 38314028
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and Safety of Lianhua Qingwen Capsules for COVID-19: A Propensity-Score Matched Cohort Study.
Lu Y; Zhang M; Yang QQ; Li WJ; Yang K; Hu W; Gao SY; Jiang QL; Lin LK; Cheng H; Sun F
Evid Based Complement Alternat Med; 2023; 2023():6028554. PubMed ID: 36846053
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19).
Zhuang J; Dai X; Wu Q; Cai H; Fu X; Zhang W; Chen B
Complement Ther Med; 2021 Aug; 60():102754. PubMed ID: 34153446
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of Lianhua Qingwen as an adjuvant treatment for influenza in Chinese patients: A meta-analysis.
Yuan C; Guan Y
Medicine (Baltimore); 2024 Jan; 103(3):e36986. PubMed ID: 38241551
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of Lianhua Qingwen (LHQW) for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis.
Zhang Q; Cao F; Ji G; Xu X; Sun Y; Li J; Qi X; Sun S; Wang Y; Song B
Medicine (Baltimore); 2020 Jul; 99(30):e20979. PubMed ID: 32791675
[TBL] [Abstract][Full Text] [Related]
14. [Network Meta-analysis of oral Chinese patent medicines in treatment of acute exacerbation of chronic obstructive pulmonary disease].
Ding MY; Yang SG; Yu NX; Hong YZ; Ye ZC; Yu XQ
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3373-3385. PubMed ID: 37382020
[TBL] [Abstract][Full Text] [Related]
15. Traditional Chinese medicine as an adjunctive therapy for mild and common COVID-19: A systematic review and network meta-analysis.
Wu X; Li W; Qin Z; Xue L; Huang G; Luo Z; Chen Y
Medicine (Baltimore); 2021 Oct; 100(40):e27372. PubMed ID: 34622839
[TBL] [Abstract][Full Text] [Related]
16. [Clinical trials and evaluation of Chinese patent medicine for influenza].
Sheng XD; Chen Z; Ji ZC; Hu HY; Ou Y; Cao LJ; Guo LP; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2338-2342. PubMed ID: 35531681
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials.
Liang SB; Fang M; Liang CH; Lan HD; Shen C; Yan LJ; Hu XY; Han M; Robinson N; Liu JP
Complement Ther Med; 2021 Aug; 60():102744. PubMed ID: 34091029
[TBL] [Abstract][Full Text] [Related]
18. Effects of Lianhua Qingwen on Pulmonary Oxidative Lesions Induced by Fine Particulates (PM2.5) in Rats.
Ping F; Li Z; Zhang F; Li D; Han S
Chin Med Sci J; 2016 Nov; 31(4):233-8. PubMed ID: 28065220
[TBL] [Abstract][Full Text] [Related]
19. [Systematic review and Meta-analysis of efficacy and safety of Shufeng Jiedu Capsules in treatment of influenza].
Zhou F; Zhao GZ; Li B; Xu XL; Shi YF; Mao YY; Tian JH; Liu QQ
Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(22):6216-6224. PubMed ID: 38114228
[TBL] [Abstract][Full Text] [Related]
20. [Babaodan Capsules for viral hepatitis: systematic review of clinical efficacy and safety and Meta-analysis of randomized clinical trials].
Yang HX; Gou J; Huang P; Dai YY; Zhang XW; Xin Y; Zhao GZ; Li B
Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(22):4953-4961. PubMed ID: 31872606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
